HIF1A and prostate carcinoma: As observed in prostate cancer PC-3 and LNCaP cells, the interaction of 38 with the N-terminal ATP binding domain of HSP90 induces destabilization and degradation of numerous HSP90 client proteins by the ubiquitin–proteasome pathway, among them HIF-1α [222,223].